chrisvoncsefalvay/vaers-outcomes huggingface dataset:
laying in bed all day; tired; a little bit odd; walking up a stairs she felt breathless; she also has a funny feeling under the armpit; kind of weird; slight chills; a feeling of malaise; a feeling of unwellness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (kind of weird), CHILLS (slight chills), MALAISE (a feeling of unwellness), DECUBITUS ULCER (laying in bed all day) and FATIGUE (tired) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included TERIPARATIDE (FORTEO) and DIAZEPAM (VALIUM) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced FEELING ABNORMAL (kind of weird), CHILLS (slight chills) and MALAISE (a feeling of unwellness). On 16-Feb-2021, the patient experienced DECUBITUS ULCER (laying in bed all day), FATIGUE (tired), FEELING ABNORMAL (a little bit odd), DYSPNOEA (walking up a stairs she felt breathless) and FEELING ABNORMAL (she also has a funny feeling under the armpit). On 10-Feb-2021, FEELING ABNORMAL (kind of weird), CHILLS (slight chills) and MALAISE (a feeling of unwellness) had resolved. At the time of the report, DECUBITUS ULCER (laying in bed all day), FATIGUE (tired), FEELING ABNORMAL (a little bit odd), DYSPNOEA (walking up a stairs she felt breathless) and FEELING ABNORMAL (she also has a funny feeling under the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications .Forteo , Valium Treatment details were not provided
Care taker of pt. called the nurse on 04/09/2021 at 5:51PM and reported that the pt. was experiencing facial edema on right side involving the back jaw, ear and cheek. The caretaker denied that pt. was experiencing hearing issues, throat /ss, visual distrubances or difficulty breathing. Caretaker of pt reported giving pt. a benedryl before calling the line. Nurse instructed caller to take Patient to ER. Upon follow up with Patient on 04/13/2021, he reported that he did take Patient to ER on 04/09/2021 where Patient received steriod injection as a precaution. ER doctor told patient and caretaker that it was
Severe sore throat, shortness of breath, cough, some fevers and mylagias.
This patient apparently  had a vaccine on 4/13 and   then showed up at the same clinic  on 4/15/21 and got a second dose of Moderna
Hives, swelling, redness. Treatment: Ice pack, ADVIL, take antihistamine for next 4-5 days.
Diarrhea & NauseaVomiting Narrative:  jaw pain, metallic taste, cramps
The patient was visiting, where she received the Men B vaccine about 2 weeks before presenting to our hospital gravely ill. Within days of receiving the vaccine she developed malaise. A few days before presenting to our hospital she developed subjective fevers and worsening malaise. On the day of presentation she had persistent vomiting, then had a seizure (no history of seizures) that was treated with anti-epileptics at an outside hospital. She was transferred to our institution and, en route, developed agonal breathing and abnormal posturing, with uncal herniation found on head CT soon after arrival. She received ceftriaxone and acyclovir and underwent external ventricular drain placement, but was declared brain dead <24 hours after arrival at our hospital. Autopsy is underway, but no causative agent has been identified yet.  - Note: As the MenB vaccine was given somewhere else, we do not know the exact date / details of the vaccine (date listed in this form is estimated, as the family stated it was given 2 weeks before she presented to our hospital on 7/4/19)
No adverse event; vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 30Jul2022; Administered the vaccine to patient after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), NO ADVERSE EVENT (No adverse event) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 30Jul2022) in a 23-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 30Jul2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), NO ADVERSE EVENT (No adverse event) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 30Jul2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 30Jul2022).    No concomitant medications were provided by the reporter.  The number of doses/vials administered were 35 vials. Date the vial was initially stored in the refrigerator was 04-Jun-2022. The vaccines were administered from the 04-Jun-2022 until the 26-Jul-2022. The vial did not undergo any temperature excursions.  No treatment medications were provided by the reporter
Swelling and redness at injection sited on 6/12/2008. Left thigh silver dollar size- right thigh quarter size. Went to after hours clinic on 6/14/2008 because Left thigh now has painful, red, hot swelling baseball size. Prednisone once a day  x 3 days and Benadryl prescribed by after hours clinic.
Fatigue Narrative: Comments: MAR 05, 2021@10:16:17 by ORIGINATOR Morning after receiving first dose of moderna covid19 vaccine patient reports he was very nauseated and fatigue throughout the day. He did take zofran, that helped. Symptoms were gone the following day. States he is often nauseated when he is dehydrated. Note that ADR was entered on day that pt received second COVID-19 vaccination
Patient was 17 years old. Under the age of 18 and should not have been given the vaccine
it has been over six months since / patient received her first dose (11/4/2020) / due to Covid-19; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 4th November 2020, in left deltoid, batch number 52F7X, expiry date 31st october 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, the patient did not receive 2nd dose of Shingrix, due to covid 19. The pharmacist's plan was to gave dose 2 to the patient on the day of reporting. The VAERS details were provided for 1st dose. The reporter consented to follow up.
rash on legs/rash on right arm; bumpy rash where the injection; swelling on her arm where the injection; itching on her arm where the injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itching on her arm where the injection), RASH (rash on legs/rash on right arm), INJECTION SITE RASH (bumpy rash where the injection) and INJECTION SITE SWELLING (swelling on her arm where the injection) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy and Drug allergy (Aspirin). Concomitant products included MONTELUKAST and EPINEPHRINE (EPIPEN) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced INJECTION SITE PRURITUS (itching on her arm where the injection), INJECTION SITE RASH (bumpy rash where the injection) and INJECTION SITE SWELLING (swelling on her arm where the injection). On 26-Feb-2021, the patient experienced RASH (rash on legs/rash on right arm). At the time of the report, INJECTION SITE PRURITUS (itching on her arm where the injection), RASH (rash on legs/rash on right arm), INJECTION SITE RASH (bumpy rash where the injection) and INJECTION SITE SWELLING (swelling on her arm where the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
My Tinnitus got much worse within 36 hours of the second Pfizer JAB
pt recvd vax & was jerking; pupils dilated; frothing at mouth; pt fainted & had a sz;
Pain in arm at injection site ever since shot was administered and  Severe muscle ache for 2 months also pain when sleeping and can?t lift anything.. I am icing it and trying not to use it.
Seizures. Child had 8 seizures in 7 hrs. which put her in a state of catatonia and was hospitalized for 19 days.
No adverse effects were felt by me after my first shot except I was extremely tired for about 2-3 days after receiving it. But after receiving my second dose of my covid 19 shot on August 27th, 2021 about 1.5 to 2 weeks later I started noticing pain, aching, and stiffness from my knees down on both legs. This lasted for about 2 months and went away after that luckily.  It made me feel like I had arthritis in my lower legs. I am only 28 but I felt as though my legs were that of an 80 year olds for those 2 months that those pains persisted in my legs (from knees down). The pain was wort in the mornings and in the evenings.
no adverse events reported; Caller inquiring about revaccination regarding an expired dose of PROQUAD administered to two different patients on two separate days.; This spontaneous report was received from a registered nurse and a consumer (patient's mother) referring to a male patient of unknown age. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 23-MAR-2022, the patient was vaccinated with an expired dose measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (strength and route were not reported; lot # T029102, expiration date: 23-FEB-2022) for prophylaxis (expired product administered). No other adverse events were reported.
Temp 103.2 - 24 hour - antipyretics, body aches, chills
Pneumococcal 23 given SQ to patient, returned next day with swollen painful arm. Admitted 3/17 - 3/19 for cellulitis at injection site.
pt recv vax & approx 5hr p/vax T106R & given APAP-sz occurred 15min later;was seen in ER & dx w/ear infect & possible rxn to pertussis;
We received from a consumer on 15 OCT 2007: A 55-year-old man, was vaccinated with Fluvirin, batch-no. 81454 G and 78990 reported, i.m. on 09 OCT 2007. The patient stated that within 1 minute after the vaccination he began to feel "totally out of it", "my heart began to beat very fast, I became instantly fatigued". On 15 OCT 2007 the patient was questioned as to whether he had any continuing symptoms, he promptly responded, 'I have every symptom". Multiple attempts were made to determine exact symptoms but outside a single mention of pneumonia, the patient always responded with "I have every symptom". Additionally, he stated that, "if I were to tell you one or two then you will miss them all". He would not expound upon his pneumonia symptoms. Company assessment: Seriousness criterion: medically significant. Causality: unrelated. Pneumonia is in most cases of bacterial or viral origin and inactivated influenza vaccines are not known to be able to cause pneumonia. Diagnosis has not been assured.
Itchy non-raised rash on right arm. IM pain went away 3 days after the vaccine was administered, but IM pain returned with onset of rash on day 10.
Ringing in ears sore left arm upper injunction site high swollen bump  worst after second injection been to ENT TINITUIS CAUSED BY INJECTION been to primary care and orthopedic doctor  ultrasound confirmed benign lymphoma caused by improperly injecting vaccine
On 3/3/22 I woke up my right arm ached and felt like it was going to fall off, just ached. I also had a headache and just body aches, the headache wasn't extreme like a COVID-19 headache and it lasted for just about 24 hours and the next day my head didn't hurt nor my body and I was fine. I took some TYLENLOL for the pain.
vasculitis; Wagner disease; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "She is a controlled diabetic" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 4 (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: VASCULITIS (non-serious), outcome "unknown"; WAGNER'S DISEASE (non-serious), outcome "unknown", described as "Wagner disease". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Reporter stated she was previously talking with a safety agent. Reporter was not provided a reportum. The Reporter stated she was diagnosed with vasculitis and Wagner disease. She was a controlled diabetic, stated her Hemoglobin A1c levels were on 5.9%. She was concerned that the vasculitis was caused by the Pfizer COVID-19 vaccine. She has had five doses of the Pfizer Biontech COVID-19 vaccine the last one was on 08Sep2022. Reporter stated that what she was experiencing was very painful. Asked if there was any information or clinical trials reporting vasculitis as a side effect of the Pfizer COVID-19 vaccine.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
pt recv vax 23OCT96 & pt exp myalgia, h/a, temp up to 100.5 & productive cough;13DEC96 a nasal swab was positive for influenza A;MD prescribed amantadine;pt reports feeling better not 100%;this case was reported by pt who is also a LPN;
Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Hyperventilation-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Patient presented with soarness in throat a couple of hours after administration. SHe was taken to the fire department (Uncertain about what treatment was conducted here). Next day, and patient is still not fully recovered. Still has scracthy throat and soreness in her throat.
Pt in for complete physical on 06/27/06 and a pnemovax was administered.  Pt called on 6/29/06 & c/o redness, swelling, and discomfort at injection site as well as a fever.  Pt instructed to use tylenol or ibuprofen as needed and to call if symptoms worsened or did not improve.
excruciating pain in her stomach; could not sleep at night; chills; sweating; she was sweating cold chills, then hot; diarrhea; she had severe abdomen pain in her right lower side; This is a spontaneous report from a contactable consumer (patient). This 36-year-old female patient (pregnant no) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm right on an unspecified date (Lot Number: Ek0153) at age of 36-year-old as unknown, single for COVID-19 immunization.  Medical history was none. The patient's concomitant medication was none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no other medications the patient received within 2 weeks of vaccination. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in right arm on 31Mar2021 07:00 Am (Lot Number: Ek8732) at age of 35-year-old for Covid-19 Immunization. On 21Apr2021 21:00, after the second shot was way worse she could not sleep at night she was sweating cold chills, then hot. The diarrhea, her body acting that night she had severe abdomen pain in her right lower side that worked its way up to the whole right side of her stomach to all around her stomach. Went to the doctor the next day didn't do nothing assumed it was possibly a bug even though she live in the house with three other people who had none of the symptoms. The next night she was at the ER because she woke up at 3 o clock in the morning and excruciating pain in her stomach. The doctor is assuming that it was a possible side effect maybe that was just going to go away did not want to give her x-rays or a CT scan he said he did not feel it was necessary but if she wanted the radiation he will go ahead and do it. Seriousness criteria reported as disabling/incapacitating. The adverse event result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Treatment received for the adverse event included Dicyclomine 20mg. Prior to vaccination, the patient did not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2021491110 same patient, vaccine, different dose and event
Patient received the meningococcal vaccine on Tuesday 8/5/14. On Thursday he states he noticed his arms itching. A rash was on his arms and throughout the day spread to his trunk, back and legs.
soreness in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the left arm) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concomitant products included METFORMIN for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness in the left arm). On 18-Jan-2021, PAIN IN EXTREMITY (soreness in the left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up information received on 16-Apr-2021 contains non-significant information of reporter email address.
VASCULAR INFLAMMATION; This spontaneous report received from a health care professional concerned a 68 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no underlying health conditions and never had coronavirus disease-19 (COVID-19), and ruled out risk factors including no genetic variants for increased risk in underlying health conditions confirmed by medical testing and no increased risk for blood clotting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 14-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced vascular inflammation. Laboratory data (dates unspecified) included: IgG (NR: not provided) negative, robust, and Laboratory test (NR: not provided) no conditions. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from vascular inflammation. This report was non-serious. This case, from the same reporter is linked to 20211032197.
After receiving the first vaccine, my arm hurt all the way to my wrist and became weak. Lasted almost till I got my second vaccine.  The second vaccine is causing the same thing.  My muscles in my upper arm hurt really bad, the pain goes down to my wrist and my arm is weak. Its been 4 days since the second vaccine and its not stopped at all.
very sore from naval to chin; trigger finger; hands painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (hands painful), TRIGGER FINGER (trigger finger) and MYALGIA (very sore from naval to chin) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (hands painful). On 25-Feb-2021, the patient experienced TRIGGER FINGER (trigger finger). On 20-Mar-2021, the patient experienced MYALGIA (very sore from naval to chin). At the time of the report, PAIN IN EXTREMITY (hands painful), TRIGGER FINGER (trigger finger) and MYALGIA (very sore from naval to chin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment include steroid and ketorolac injection.
The night of the vaccine, I began having hot flashes through the night. I didn't worry about it because I assumed it was normal. What does not seem normal is the fact that the hot flashes have continued. I'm now more than 3 weeks post vaccination, and each night I have multiple hot flashes all night long. I did not have any hot flashes before this vaccine.
Roughly 5 minutes after I administered the vaccine she complained of dizziness. I had her sit back on the chair and gave her H2O. Shortly after she said she was having a hard time breathing. I then called 911. They ruled out any anaphylaxis and said it was an anxiety attack. She was fine 30 min later.
Pt recv vax on 3/17/98; vax expiration date was 1/6/98.  Pt did not exp rx.
Information as received from a certified medical assistant (CMA) refers to an 18-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 04-JUN-2015, the patient was vaccinated with a dose of GARDASIL (lot number K014191 and expiration date 10-MAY-2017) (dose and route not reported) which was improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
12/24/22 presents to ED for "fever, N/V". PMHx of "Addisons, Met Breast CA"